Decheng Capital Llc Portfolio Stock Holdings
Decheng Capital Llc disclosed 14 stock positions valued at approximately $661.3 million in its latest SEC 13F filing. The largest holdings include CG ONCOLOGY INC, Nuvation Bio Inc., and Aclaris Therapeutics, Inc.. The filing reflects positions held as of March 31, 2026 and was filed on May 13, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 14
- Portfolio Value
- $661.3M
Holdings by Sector
Decheng Capital Llc Portfolio Holdings in Q1 2026
11 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| CG ONCOLOGY INC | CGON | Healthcare | 65.21% | 6,371,669 | - | - | $431,234,558 |
| Nuvation Bio Inc. | NUVB | Healthcare | 16.84% | 25,954,439 | - | - | $111,344,543 |
| Aclaris Therapeutics, Inc. | ACRS | Healthcare | 2.29% | 4,041,736 | - | - | $15,156,510 |
| Lyell Immunopharma, Inc. | LYEL | Healthcare | 2.10% | 692,050 | - | - | $13,882,523 |
| NEWAMSTERDAM PHARMA CO NV | NAMSW | Other | 1.57% | 325,057 | -267,000 | -45.10% | $10,405,075 |
| Arcus Biosciences, Inc | RCUS | Healthcare | 1.56% | 477,819 | -63,740 | -11.77% | $10,320,890 |
| REVOLUTION MEDICINES INC(NSM) | RVMD | Healthcare | 1.37% | 93,500 | -106,500 | -53.25% | $9,092,875 |
| Equillium Inc. | EQ | Healthcare | 1.34% | 4,447,308 | - | - | $8,894,616 |
| Zentalis Pharmaceuticals Inc. | ZNTL | Healthcare | 0.47% | 1,323,327 | - | - | $3,096,585 |
| KRYSTAL BIOTECH INC | KRYS | Healthcare | 0.29% | 7,300 | -10,000 | -57.80% | $1,885,736 |
| Pyxis Oncology, Inc (formerly Apexigen) | PYXS | Healthcare | 0.07% | 326,810 | - | - | $477,143 |